Applying the Medical Home Model to Advance the Management of COPD

Applying the Medical Home Model to Advance the Management of COPD

On-Demand Webcast

This webcast is based on live proceedings from the 2017 Patient-Centered Medical Home Congress.

Provided by North American Center for Continuing Medical Education, LLC, an HMP Company, and the National Committee for Quality Assurance




















Fernando J. Martinez, MD
Chief of the Division of Pulmonary and Critical Care Medicine
Weill Cornell Medical College
New York-Presbyterian Hospital/Weill Cornell Medical Center
New York, New York

Chris Espersen, MSPH
Chris Espersen Consulting
Des Moines, Iowa

Intended Learners

This activity is designed for professionals devoted to transforming care through the medical home model of care, including primary care clinicians, allied health professionals, practice administrators, and quality managers.

Learning Objectives

After completion of this activity, participants should be able to:

  • Routinely utilize spirometry to properly assess and diagnosis COPD in at-risk patient populations
  • Implement guideline directed care for the pharmacotherapeutic management of COPD exacerbations, including preventative, maintenance, and long-term interventions
  • Explain the latest data on currently available and emerging COPD therapies
  • Counsel patients on the appropriate use of inhaler medications, while recognizing signs for medication failure and noncompliance
  • Evaluate the potential impact of the PCMH model on the quality of COPD care, patient outcomes, and cost drivers
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 60% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring webcast.

Release Date: April 18, 2018
Expiration Date: April 18, 2019
Estimated time to complete: 30 minutes

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions to


In support of improving patient care, the National Committee for Quality Assurance (NCQA) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE) and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.


NCQA designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This educational activity is approved for 0.5 nursing education contact hour.


This activity is approved for 0.5 contact hour (.005 CEU) of continuing pharmacy education (UAN JA0004597-0000-18-012-H04-P).

This educational activity is a knowledge-based activity.

Clinical Reviewer: Craig R. Rackley, MD, Assistant Professor, Duke University Medical Center, Durham, NC

Nurse Reviewer: Johann Chanin, Senior Consultant, Steadman Group, Denver, CO

Planning Committee

The planning committee comprises  Johann Chanin, MSN, RN, PCMH CCE, Chris Espersen, MSPH, Fernando J Martinez, MD, Craig R. Rackley, MD; Vashon Coehins, Tina Coffron, and Bart Ecker, NCQA; and Kristin Ciszeski, Mary Johnson, Michael Kearney, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Martinez: Advisory board/consultant—AstraZeneca, Boehringer Ingelheim, ConCert, Genentech, GlaxoSmithKline, Nitto, Unity, Novartis, Patara, Pearl, Proterrix Bio, and Theravance; Steering committee—Afferent, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Gilead, Veracyte; Speakers bureau/CME—AstraZeneca, Boehringer Ingelheim, Columbia University, GlaxoSmithKline, Inova Health System, Integritas, Methodist Hospital, Miller Communications, New York University, Novartis, PeerView, Potomac, Prime, Puerto Rican Respiratory Society, Chiesi/Respiration Day, University of Alabama Birmingham, UpToDate, WebMD/MedScape, Western Connecticut Health Network; Data and safety monitoring board—Biogen, Boehringer Ingelheim, GlaxoSmithKline.

Ms. Chanin, Ms. Espersen, and Dr. Rackley disclosed no relevant financial relationships with any commercial interests.

Ms. Coehins, Ms. Coffron, Mr. Ecker, Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed no off label/unapproved uses of drugs and/or devices will be discussed in the presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from GlaxoSmithKline